NCT03702556

Brief Summary

Rationale: To study the effects of mastectomy and autologous breast reconstruction on the sensation of the (reconstructed) breast, not only the peripheral reinnervation of the breast should be studied, but also the changes that take place in the somatosensory cortex. Now that the region of interest in the brain and the somatotopy of the non-operated breast are known, studies with patients who underwent mastectomy and breast reconstruction are the next step to understand the neuroplasticity of the brain following breast surgery. Objective: To study the neuroplasticity of the brain after mastectomy and breast reconstructive surgery by assessing the somatotopy of the breast on the somatosensory cortex of patients who underwent either breast reconstruction with and without nerve restoration or mastectomy without breast reconstruction. Study design: A single center imaging study carried out in Maastricht University Medical Center. Study population: A total of 30 female breast cancer patients who underwent a unilateral mastectomy without breast reconstruction or a mastectomy followed by a unilateral autologous breast reconstruction with a deep inferior epigastric artery perforator (DIEP) flap will be included in this study. Three groups of patients will be selected and compared: ten patients who underwent a mastectomy without breast reconstruction, ten patients who underwent a DIEP flap breast reconstruction with sensory nerve restoration of the flap and ten patients who underwent a DIEP flap without nerve restoration. Intervention: Every subject will undergo a single functional MRI scan in a 7 Tesla MRI scan at least six months after the operation. A scanning session takes approximately 75 minutes. During the scan, piezo-electric stimulators are applied to both the reconstructed and non-operated breast in a fixed pattern. These stimulators stimulate the skin and sensory nerves of the breast and nipple-areola complex in a random sequence. Main study parameters: The hemodynamic response after stimulation of the skin of the breast and nipple-areola complex, representing neuronal activity in that region, is measured. Within the somatosensory cortex (S1 and S2), the temporo-spatial brain activity patterns after the various stimulation conditions are assessed, and the representation of the breast on the somatosensory cortex is mapped.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 11, 2018

Completed
1.3 years until next milestone

Study Start

First participant enrolled

February 11, 2020

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2023

Completed
Last Updated

August 24, 2023

Status Verified

August 1, 2023

Enrollment Period

3.5 years

First QC Date

October 7, 2018

Last Update Submit

August 23, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The neuroplasticity of the brain after breast reconstruction

    Changes in the blood oxygen level dependent (BOLD) contrast as a function of vibrotactile stimulation of the breast and nipple-areola complex will be measured. Changes will be analysed using multi-voxel pattern analysis to localize the different parts of the breast in the somatosensory cortex.

    75 minutes

Secondary Outcomes (2)

  • Differences in the somatotopy between patients who underwent a breast reconstruction with nerve restoration compared to patients who underwent breast reconstruction without nerve restoration.

    75 minutes

  • Differences in the somatotopy between patients who underwent mastectomy without breast reconstruction compared to patients who underwent breast reconstruction.

    75 minutes

Study Arms (3)

Mastectomy without breast reconstruction

ACTIVE COMPARATOR

Functional MRI scan of the somatosensory cortex while the breast skin is stimulated by piezo-stimulators.

Device: MRI scan

Breast reconstruction with nerve

ACTIVE COMPARATOR

Functional MRI scan of the somatosensory cortex while the breast skin is stimulated by piezo-stimulators.

Device: MRI scan

Breast reconstruction without nerve

ACTIVE COMPARATOR

Functional MRI scan of the somatosensory cortex while the breast skin is stimulated by piezo-stimulators.

Device: MRI scan

Interventions

MRI scanDEVICE

7.0 tesla functional MRI scan

Breast reconstruction with nerveBreast reconstruction without nerveMastectomy without breast reconstruction

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female over 18 years old
  • Unilateral mastectomy without breast reconstruction
  • Unilateral mastectomy with DIEP flap breast reconstruction (with or without sensory nerve restoration)
  • At least six months after the operation
  • Informed consent

You may not qualify if:

  • Bilateral mastectomy / breast reconstruction
  • Previous surgery, disease or treatment of the contralateral breast
  • Active disease / metastasis
  • Previous radiation therapy on the chest or axilla
  • Diseases associated with neuropathy (e.g. diabetes mellitus)
  • Previous brain surgery
  • Previous allergic reactions to adhesives or plasters
  • No piercings or other iron materials (except a metal brace behind front teeth)
  • Claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University Medical Center

Maastricht, Limburg, 6229 HX, Netherlands

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • René Van der Hulst, MD, PhD

    Maastricht University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2018

First Posted

October 11, 2018

Study Start

February 11, 2020

Primary Completion

August 15, 2023

Study Completion

August 15, 2023

Last Updated

August 24, 2023

Record last verified: 2023-08

Locations